BidaskClub upgraded shares of Castlight Health, inc. (NYSE:CSLT) from a strong sell rating to a sell rating in a report released on Wednesday.

Several other equities research analysts also recently issued reports on the stock. Zacks Investment Research upgraded shares of Castlight Health, inc. from a sell rating to a hold rating in a research note on Tuesday, June 27th. ValuEngine downgraded shares of Castlight Health, inc. from a hold rating to a sell rating in a research note on Friday, May 19th. Chardan Capital initiated coverage on shares of Castlight Health, inc. in a research note on Tuesday, June 6th. They issued a buy rating and a $4.50 target price for the company. Cowen and Company reiterated a market perform rating and issued a $4.50 target price (up from $4.00) on shares of Castlight Health, inc. in a research note on Thursday, August 3rd. Finally, Dougherty & Co reiterated a buy rating on shares of Castlight Health, inc. in a research note on Thursday, August 17th. Three investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. Castlight Health, inc. presently has a consensus rating of Hold and an average price target of $4.57.

Castlight Health, inc. (NYSE:CSLT) opened at 4.05 on Wednesday. Castlight Health, inc. has a 52-week low of $3.05 and a 52-week high of $5.50. The company’s 50 day moving average price is $3.99 and its 200 day moving average price is $3.89. The firm’s market cap is $533.33 million.

Castlight Health, inc. (NYSE:CSLT) last issued its earnings results on Wednesday, August 2nd. The software maker reported ($0.07) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.02. Castlight Health, inc. had a negative net margin of 42.54% and a negative return on equity of 36.30%. The business had revenue of $32.10 million during the quarter, compared to the consensus estimate of $31.14 million. During the same period last year, the business posted ($0.11) EPS. Castlight Health, inc.’s revenue was up 36.0% on a year-over-year basis. Analysts predict that Castlight Health, inc. will post ($0.25) earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This article was published by Daily Political and is the property of of Daily Political. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/09/17/castlight-health-inc-cslt-raised-to-sell-at-bidaskclub.html.

In other Castlight Health, inc. news, insider Giovanni M. Colella sold 23,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $4.06, for a total transaction of $93,380.00. Following the completion of the sale, the insider now directly owns 78,906 shares in the company, valued at $320,358.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Giovanni M. Colella sold 8,100 shares of the firm’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $3.67, for a total transaction of $29,727.00. Following the sale, the insider now owns 97,969 shares of the company’s stock, valued at $359,546.23. The disclosure for this sale can be found here. Insiders have sold 208,287 shares of company stock valued at $795,240 over the last 90 days. Company insiders own 37.43% of the company’s stock.

A number of hedge funds have recently modified their holdings of CSLT. Oxford Asset Management acquired a new stake in Castlight Health, inc. during the first quarter worth approximately $102,000. Voya Investment Management LLC lifted its position in Castlight Health, inc. by 25.4% during the second quarter. Voya Investment Management LLC now owns 26,929 shares of the software maker’s stock worth $112,000 after acquiring an additional 5,453 shares during the last quarter. Stifel Financial Corp lifted its position in Castlight Health, inc. by 4.3% during the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock worth $133,000 after acquiring an additional 1,500 shares during the last quarter. Nationwide Fund Advisors lifted its position in Castlight Health, inc. by 49.5% during the second quarter. Nationwide Fund Advisors now owns 36,418 shares of the software maker’s stock worth $151,000 after acquiring an additional 12,061 shares during the last quarter. Finally, FNY Partners Fund LP acquired a new stake in Castlight Health, inc. during the first quarter worth approximately $164,000. Hedge funds and other institutional investors own 41.30% of the company’s stock.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.